APA (7th ed.) Citation

Soldati, S., Bär, A., Vladymyrov, M., Glavin, D., McGrath, J. L., Gosselet, F., . . . Engelhardt, B. (2023). High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro. Journal of Neuroinflammation, 20(1), 1. https://doi.org/10.1186/s12974-023-02797-8

Chicago Style (17th ed.) Citation

Soldati, Sasha, Alexander Bär, Mykhailo Vladymyrov, Dale Glavin, James L. McGrath, Fabien Gosselet, Hideaki Nishihara, Susan Goelz, and Britta Engelhardt. "High Levels of Endothelial ICAM-1 Prohibit Natalizumab Mediated Abrogation of CD4+ T Cell Arrest on the Inflamed BBB Under Flow in Vitro." Journal of Neuroinflammation 20, no. 1 (2023): 1. https://doi.org/10.1186/s12974-023-02797-8.

MLA (9th ed.) Citation

Soldati, Sasha, et al. "High Levels of Endothelial ICAM-1 Prohibit Natalizumab Mediated Abrogation of CD4+ T Cell Arrest on the Inflamed BBB Under Flow in Vitro." Journal of Neuroinflammation, vol. 20, no. 1, 2023, p. 1, https://doi.org/10.1186/s12974-023-02797-8.